Cannabis Bioscience International Holdings, Inc. (CBIH) Non Operating Interest Expenses (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Non Operating Interest Expenses across 5 years of filings, most recently posting $10776.0 for Q1 2026.

• In Q1 2026, Non Operating Interest Expenses fell 52.05% year-over-year to $10776.0; the TTM figure through Feb 2026 stood at $148753.0 (up 13.28% YoY), while the FY2025 annual figure was $136262.0, down 11.64% from the prior year.
• Non Operating Interest Expenses came in at $10776.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $17860.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $102749.0 in Q2 2025 to a low of $1206.0 in Q2 2023.
• Average Non Operating Interest Expenses over 5 years is $31534.4, with a median of $20166.5 recorded in 2025.
• The largest YoY upside for Non Operating Interest Expenses was 7802.32% in 2024 against a maximum downside of 62.56% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $36278.0 in 2022, then declined by 17.54% to $29916.0 in 2023, then sank by 62.56% to $11200.0 in 2024, then soared by 59.46% to $17860.0 in 2025, then sank by 39.66% to $10776.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $10776.0 in Q1 2026, $17860.0 in Q4 2025, and $17368.0 in Q3 2025.